90

DAFTAR PUSTAKA

Abdulrazak, A., Ibrahim Bitar, Z., Ayesh Al-Shamali, A., Ahmed Mobasher, L.,

2005. Bacteriological Study of Diabetic Foot Infections. J. Diabetes

Complications 19, 138–141.

Akhi, M.T., Ghotaslou, R., Asgharzadeh, M., Varshochi, M., Pirzadeh, T., Memar,

M.Y., Zahedi Bialvaei, A., Seifi Yarijan Sofla, H., Alizadeh, N., 2015.

Bacterial etiology and antibiotic susceptibility pattern of diabetic foot

infections in Tabriz, Iran. GMS Hyg. Infect. Control 10, 1–6.

Alekshun, M.N., Levy, S.B., 2007. Molecular Mechanisms of Antibacterial

Multidrug Resistance. Cell 128, 1037–1050.

Alwan, A., Benhalima, K., Beran, D., Buckley, A., Brown, J., Ruth Colagiuri, G.D.,

Egede, L., Ellis, C., Griffi, S., Keeling, A., Mathieu, C., Mbanya, J.C., McGill,

M., McGuire, H., Nichols, G., Zimmet, P., 2009. IDF Diabetes Atlas.

Anonym, 2011. Peraturan Menteri Kesehatan Republik Indonesia Tentang

Pedoman Umum Penggunaan Antibiotik.

Attinger, C., Wolcott, R., 2012. Clinically Addressing Biofilm in Chronic Wounds.

Adv. wound care 1, 127–132.

Basak, S., Rajurkar, M.N., 2014. Newer β-Lactamases and E . coli — A Cause of

Concern, in: Shailendra K. Saxena (Ed.), Trends in Infectious Diseases. pp.

47–72.

Batistão, D.W.D.F., Gontijo-Filho, P.P., Conceição, N., Oliveira, A.G. De, Ribas,

R.M., 2012. Risk factors for vancomycin-resistant enterococci colonisation in

critically ill patients. Mem. Inst. Oswaldo Cruz 107, 57–63.

Benwan, K. Al, Mulla, A. Al, Rotimi, V.O., 2012. A study of the microbiology of

diabetic foot infections in a teaching hospital in Kuwait. J. Infect. Public

Health 5, 1–8.

Bereket, W., Hemalatha, K., Getenet, B., Wondwossen, T., Solomon, A., Zeynudin,

A., Kannan, S., 2012. Update on bacterial nosocomial infections. Eur. Rev.

Med. Pharmacol. Sci. 16, 1039–1044.

Blanes, J.I.M., 2011. Consensus document on treatment of infections in diabetic

foot. Rev. Esp. Quimioter. 24, 233–62.

Bockstael, K., Aerschot, A., 2009. Antimicrobial resistance in bacteria. Cent. Eur.

J. Med. 4, 141–155.

Breathnach, A.S., 2013. Nosocomial infections and Infection Control, in: Medicine.

Elsevier Ltd, pp. 557–561.

Brown, D.F.J., Edwards, D.I., Hawkey, P.M., Morrison, D., Ridgway, G.L.,

Towner, K.J., Wren, M.W.D., 2005. Guidelines for the laboratory diagnosis

91

and susceptibility testing of methicillin-resistant Staphylococcus aureus

(MRSA). J. Antimicrob. Chemother. 56, 1000–18.

Byarugaba, D.K., 2010. Mechanisms of Antimicrobial Resistance, in: Sosa, A. de

J., Byarugaba, D.K., Amabile, C., Hsueh, P.., Kariuki, S., Okeke, I.N. (Eds.),

Antimicrobial Resistance in Developing Countries. Springer, pp. 15–27.

Casqueiro, J., Casqueiro, J., Alves, C., 2012. Infections in patients with diabetes

mellitus: A review of pathogenesis. Indian J. Endocrinol. Metab. 16, S27-36.

Chadwick, P., Edmonds, M., MsCardle, J., Armstrong, D., Apelqvist, J., Botros,

M., Clerici, G., Cundell, J., Ehrler, S., Hummel, M., Lipsky, B.A., Martinez,

J.L.L., Thomas, R., Tulley, S., 2014. Best Practice Guidelines : Wound

Management in Diabetic Foot Ulcers, Wounds International. Wounds

International.

Chavan, S.K., Gs, K., Chavan, K.B., 2015. Bacterial Profile and pattern of

antimicrobial drug resistance in Diabetic foot ulcers at Tertiary care hospital.

Int. J. Med. Reasearch Rev. 3, 97–105.

Clayton, W., Elcasy, T. a., 2009. A review of the pathophysiology, classification

and treatment of foot ulcers in diabetics patients. Clin Diabetes 27, 52–58.

Datta, V., Sun, M., Industries, P., 2016. Complications and risk management of

diabetic foot ulcer : A review.

Deribe, B., Woldemichael, K., Nemera, G., 2014. Prevalence and Factors

Influencing Diabetic Foot Ulcer among Diabetic Patients Attending

Arbaminch Hospital, South Ethiopia. J. Diabetes Metab. 5, 1–6.

Drinka, P., Bonham, P., Crnich, C.J., 2012. Swab culture of purulent skin infection

to detect infection or colonization with antibiotic-resistant bacteria. J. Am.

Med. Dir. Assoc. 13, 75–79.

Furuno, J.P., Perencevich, E.N., Johnson, J.A., Wright, M.O., McGregor, J.C.,

Morris Jr., J.G., Strauss, S.M., Roghman, M.C., Nemoy, L.L., Standiford,

H.C., Hebden, J.N., Harris, A.D., 2005. Methicillin-resistant Staphylococcus

aureus and vancomycin-resistant Enterococci co-colonization. Emerg. Infect.

Dis. 11, 1539–1544.

G. Ducel, J. Fabry, L.N., 2002. Prevention of hospital-acquired infections. World

Heal. Organ. 2, 1–64. doi:WHO/CDS/CSR/EPH/2002.12

Gadepalli, R., Dhawan, B., Sreenivas, V., Kapil, A., Ammini, a. C., Chaudhry, R.,

2006. A clinico-microbiological study of diabetic foot ulcers in an Indian

tertiary care hospital. Diabetes Care 29, 1727–1732.

Galkowska, H., Podbielska, A., Olszewski, W.L., Stelmach, E., Luczak, M.,

Rosinski, G., Karnafel, W., 2009. Epidemiology and prevalence of methicillin-

resistant Staphylococcus aureus and Staphylococcus epidermidis in patients

with diabetic foot ulcers: Focus on the differences between species isolated

92

from individuals with ischemic vs. neuropathic foot ulcers. Diabetes Res. Clin.

Pract. 84, 187–193.

Geerlings, S.E., Hoepelman, a I., 1999. Immune dysfunction in patients with

diabetes mellitus (DM). FEMS Immunol. Med. Microbiol. 26, 259–265.

Ghazali, M.V., Satromihardjo, S., Soedjarwo, S.R., Soelaryo, T., Pramulyo, H.S.,

2014. Studi cross-sectional, in: Sastroasmoro, S., Ismael, S. (Eds.), Dasar-

Dasar Metodologi Penelitian Klinis. Sagung Seto, Jakarta, pp. 130–144.

Gold, H.S., 2001. Vancomycin-Resistant Enterococci: Mechanisms and Clinical

Observations. Clin. Infect. Dis. 33, 210–219.

Henriques Normark, B., Normark, S., 2002. Evolution and spread of antibiotic

resistance. J. Intern. Med. 252, 91–106.

Hidron, A.I., Kourbatova, E. V, Halvosa, J.S., Terrell, B.J., McDougal, L.K.,

Tenover, F.C., Blumberg, H.M., King, M.D., 2005. Risk factors for

colonization with methicillin-resistant Staphylococcus aureus (MRSA) in

patients admitted to an urban hospital: emergence of community-associated

MRSA nasal carriage. Clin.Infect.Dis. 41, 159–166.

Jean B. Patel, D., Franklin R. Cockerill III, M., Jeff Alder, P., Patricia A. Bradford,

P., George M. Eliopoulos, M., Dwight J. Hardy, P., Janet A. Hindler, MCLS,

M., Stephen G. Jenkins, PhD, D(ABMM), F., James S. Lewis II, P., Linda A.

Miller, P., Mair Powell, MD, FRCP, Frcp., Jana M. Swenson, Mms., Maria M.

Traczewski, BS, M., John D. Turnidge, M., Melvin P. Weinstein, M., Barbara

L. Zimmer, P., 2014. Clinical and Laboratory Standards Institute. Performance

Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth

Informational Supplement, Twenty-Fourth Informational Supplement - M100-

S24.

Ji, X., Jin, P., Chu, Y., Feng, S., Wang, and P., 2014. Clinical Characteristics and

Risk Factors of Diabetic Foot Ulcer With Multidrug- Resistant Organism

Infection. Int. J. Low. Extrem. Wounds 13, 64–71.

Kementerian Kesehatan RI, 2014. Pusat Data dan Informasi Kementerian

Kesehatan RI 2014.

Khan, H.A., Ahmad, A., Mehboob, R., 2015. Nosocomial infections and their

control strategies. Asian Pac. J. Trop. Biomed. 5, 509–514.

Klaus Kirketerp-Moller, Karen Zulkowski, G.J., 2011. Chronic Wound

Colonization, Infection, and Biofilms, in: Bjarnsholt, T. (Ed.), Biofilm

Infections. Springer, Koege, pp. 1–9.

Kolmos, H.J., 2012. Health Care Associated Infections: Sources and Routes of

Transmission. Infect. Control - Updat. 21–38.

Kruse, I., 2006. Evaluation and Treatment of Diabetic Foot Ulcers. Clin. Diabetes

24, 91–93.

93

Kumar, A., Schweizer, H.P., 2005. Bacterial resistance to antibiotics: active efflux

and reduced uptake. Adv. Drug Deliv. Rev. 57, 1486–513.

Kumar, S., Varela, M.F., 2013. Molecular mechanisms of bacterial resistance to

antimicrobial agents. Microb. Pathog. Strateg. Combat. them Sci. Technol.

Educ. 522–534.

Kurniawan, L.B., Ensa, T., Sennang, N., 2011. Aerob Microbes Pattern and

Antimicrobial Sensitivity of Diabetic Foot Ulcer. Indones. J. Clin. Pathol.

Med. Lab. 18, 1–3.

Lakshmi, G.J., 2015. Mechanism of Resistance , Phenotyping and Genotyping of

Methicillin Resistant Staphylococcus aureus : A Review. Int. J. Curr.

Microbiol. Appl. Sci. 4, 810–818.

Lakshmi, R., Nusrin, K.S., Georgy, S.A., Sreelakshmi, K.S., 2014. Role of Beta

Lactamases in Antibiotic Resistance: a Review. Int. Res. J. Pharm. 5, 37–40.

Lavery, L.A., Armstrong, D.G., Murdoch, D.P., Peters, E.J.G., Lipsky, B.A., 2007.

Validation of the Infectious Diseases Society of America ’ s Diabetic Foot

Infection Classification System.

Lavery, L.A., Armstrong, D.G., Wunderlich, R.P., Mohler, M.J., Wendel, C.S.,

Lipsky, B.A., 2006. Risk Factors for Foot Infections in Individuals With

Diabetes. Diabetes Care 29, 1288–1293.

Lavery, L.A., Fontaine, J. La, Bhavan, K., Kim, P.J., Williams, J.R., Hunt, N.A.,

2014. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic

foot infections. Diabet. Foot Ankle 5, 3–6.

Levy, S.B., Marshall, B., 2004. Antibacterial resistance worldwide: causes,

challenges and responses. Nat. Med. 10, S122–S129.

Levy Hara, G., Gould, I., Endimiani, A., Pardo, P.R., Daikos, G., Hsueh, P.-R.,

Mehtar, S., Petrikkos, G., Casellas, J.M., Daciuk, L., Paciel, D., Novelli, A.,

Saginur, R., Pryluka, D., Medina, J., Savio, E., 2013. Detection, treatment, and

prevention of carbapenemase-producing Enterobacteriaceae:

recommendations from an International Working Group. J. Chemother. 25,

129–40.

Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J.G., Armstrong,

D.G., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer, A.W., Pinzur, M.S.,

Senneville, E., 2012. 2012 Infectious Diseases Society of America Clinical

Practice Guideline for the Diagnosis and Treatment of Diabetic Foot

Infections. Clin. Infect. Dis. 54, 132–173.

Lipsky, B.A., Berendt, A.R., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer,

A.W., LeFrock, J.L., Lew, D.P., Mader, J.T., Norden, C., Tan, J.S., 2004.

Diagnosis and Treatment of Diabetic Foot Infections, in: Clinical Infectious

Disease. Electronically published, Seattle, pp. 885–910.

94

Magiorakos, A., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske,

C.G., Harbarth, S., Hindler, J.F., 2012. Bacteria : an International Expert

Proposal for Interim Standard Definitions for Acquired Resistance. Clin

Microbiol Infect 18, 268–281.

Martins, A., Hunyadi, A., Amaral, L., 2013. Mechanisms of resistance in bacteria:

an evolutionary approach. Open Microbiol. J. 7, 53–8.

Mendes, J., Neves, J., 2012. Diabetic Foot Infections: Current Diagnosis and

Treatment. J. Diabet. Foot Complicat. 4, 26–45.

Mendes, J.J., Marques-Costa, A., Vilela, C., Neves, J., Candeias, N., Cavaco-Silva,

P., Melo-Cristino, J., 2012. Clinical and bacteriological survey of diabetic foot

infections in Lisbon. Diabetes Res. Clin. Pract. 95, 153–161.

Mulvey, M.R., Simor, A.E., 2009. Antimicrobial resistance in hospitals: How

concerned should we be? Cmaj 180, 408–415.

Murali, T.S., Kavitha, S., Spoorthi, J., Bhat, D. V, Prasad, A.S.B., Upton, Z.,

Ramachandra, L., Acharya, R. V, Satyamoorthy, K., 2014. Characteristics of

microbial drug resistance and its correlates in chronic diabetic foot ulcer

infections Isolation of bacteria. J. Med. Microbiol. 63, 1377–1385.

Noor, S., Zubair, M., Ahmad, J., 2015. Diabetic foot ulcer-A review on

pathophysiology, classification and microbial etiology. Diabetes Metab.

Syndr. Clin. Res. Rev. 9, 192–199.

Nordmann, P., Dortet, L., Poirel, L., 2012. Carbapenem resistance in

Enterobacteriaceae: Here is the storm! Trends Mol. Med. 18, 263–272.

Paterson, D.L., Bonomo, R.A., 2005. Extended-Spectrum β-Lactamases: a Clinical

Update. Clin. Microbiol. Rev. 18, 657–686. doi:10.1128/CMR.18.4.657

Pop-Vicas, A.E., D’Agata, E.M.C., 2005. The rising influx of multidrug-resistant

gram-negative bacilli into a tertiary care hospital. Clin. Infect. Dis. 40, 1792–

1798.

Rebolledo, F.A., Soto, J.M.T., Jorge Escobedo de la Peña, 2011. The Pathogenesis

of the Diabetic Foot Ulcer : Prevention and Management, in: Dinh, T. (Ed.),

Global Perspective on Diabetic Foot Ulcerations. InTech China, Shanghai, pp.

155–178.

Richard, J.-L., Sotto, A., Lavigne, J.-P., 2011. New insights in diabetic foot

infection. World J. Diabetes 2, 24–32.

Richard, J.L., Sotto, A., Jourdan, N., Combescure, C., Vannereau, D., Rodier, M.,

Lavigne, J.P., 2008. Risk factors and healing impact of multidrug-resistant

bacteria in diabetic foot ulcers. Diabetes Metab. 34, 363–369.

Roberts, A.D., Simon, G.L., 2012. Diabetic Foot Infections: The Role of

Microbiology and Antibiotic Treatment. Semin. Vasc. Surg. 25, 75–81.

95

Rodrigues, J., Mitta, N., 2011. Diabetic Foot and Gangrene, in: Vitin, A. (Ed.),

Gangrene - Current Concepts and Management Options. InTech China,

Shanghai, pp. 121–144.

Sevanan, M., Jayanthi, Devi, P.U., John, P.N., 2011. Prevalence and antimicrobial

susceptibility pattern of Extended Spectrum beta -Lactamases producing

Escherichia coli in diabetic foot infection. Res. J. Microbiol. 6, 609–617.

Shahi, S., Kumar, a, Kumar, S., Singh, S., Gupta, S., Singh, T., 2012. Prevalence

of Diabetic Foot Ulcer and Associated Risk Factors in Diabetic Patients From

North India. J. Diabet. Foot Complicat. 4, 83–91.

Siegel, J.D., Rhinehart, E., Cic, R.N.M.P.H., Jackson, M., Brennan, P.J., Bell, M.,

2006. Management of Multidrug-Resistant Organisms In Healthcare Settings.

Centers Dis. Control Prev.

Singh, S., Pai, D.R., Yuhhui, C., 2013. Diabetic Foot Ulcer – Diagnosis and

Management. Clin. Res. Foot Ankle 1, 1–9.

Spear, B.M., 2014. When and how to culture a chronic wound. Wound Care Advis.

Trivedi, U., Parameswaran, S., Armstrong, A., Burgueno-Vega, D., Griswold, J.,

Dissanaike, S., Rumbaugh, K.P., 2014. Prevalence of Multiple Antibiotic

Resistant Infections in Diabetic versus Nondiabetic Wounds. J. Pathog. 2014,

1–6.

Wahab, N. hilda H.A., Samsudin, I.N., Nordin, S.A., Ahmad, Z., Noor, L.A.M.,

Devnani, A.S., 2015. Clinical presentation and microorganisms sensitivity

profile for diabetic foot ulcers: A pilot study. Med. J. Malaysia 70, 182–187.

Wang, S.-H., Sun, Z.-L., Guo, Y.-J., Yang, B.-Q., Yuan, Y., Wei, Q., Ye, K.-P.,

2010. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in

diabetic patients in a Chinese care hospital: risk factors for infection and

prevalence. J. Med. Microbiol. 59, 1219–1224.

Yerat, R.C., Rangasamy, V.R., 2015. A clinicomicrobial study of diabetic foot ulcer

infections in South India. Int. J. Med. Public Heal. 5, 236–241.

Zubair, M., Malik, A., Ahmad, J., 2011. Clinico-microbiological study and

antimicrobial drug resistance profile of diabetic foot infections in North India.

Foot (Edinb). 21, 6–14.